ApoE4: an emerging therapeutic target for Alzheimer’s disease

The growing body of evidence indicating the heterogeneity of Alzheimer’s disease (AD), coupled with disappointing clinical studies directed at a fit-for-all therapy, suggest that the development of a single ma…

Leave a Reply

Your email address will not be published. Required fields are marked *